Cat. No.: DIA-0243022
Product Information | |
---|---|
CAS No. | 1150701-66-8 |
Synonyms | SCD inhibitor 1 |
Formula | C18H16Cl2N4O2 |
Molecular Weight | 391.25 |
SMILES | ClC(C=CC(CN1N=NC(C(NC2=CC=C(CO)C=C2)=O)=C1C)=C3)=C3Cl |
Target | Stearoyl-CoA Desaturase (SCD) |
Product Description | GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase (SCD) inhibitor extracted from patent WO/2009060053 A1, compound example 16. |
Format & Storage | |
---|---|
Format | Solid |
Color | Light yellow to yellow |
Purity | 99.65% |
Shipping | Room temperature in the continental U.S. Other areas may vary. |
Storage | Powder: -20°C, 3 years; 4°C, 2 years In solvent: -80°C, 2 years; -20°C, 1 year |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.